What is the global market size of Assisted Reproductive Technology Market?

Global Assisted Reproductive Technology Market size was valued at USD 2101.5 million in 2021 and is poised to grow from USD 2507.09 million in 2022 to USD 12272.5 million by 2030, growing at a CAGR of 19.3% in the forecast period (2023-2030).

Who are the key vendors in the Global Assisted Reproductive Technology Market?

Key players in the global assisted reproductive technology market are implementing a variety of strategies such as such as product launches, investment in R&D, and the expansion of product portfolios in order to increase their market presence. For instance, in January 2021, CooperSurgical acquired Embryo Options a significant leader in cryo-storage software systems for reproductive clinics. Patients will benefit from the Embryo Options platform's online tools, which will provide information regarding stored specimens for future ART treatment cycles. Hamilton Throne Ltd., a global provider of ART research, for example, acquired IVFTECH ApS (IVFtech) and its subsidiary firm, K4 Technology ApS, in July 2021. With the assistance of its affiliated company, K4, IVFtech is committed to supplying laminar flow workstations and large-capacity incubators for ART. The deal was valued $8 million. 'CooperSurgical, Inc. (a subsidiary of The Cooper Companies Inc.)', 'Vitrolife AB', 'Ferring Pharmaceuticals Inc.', 'Cook Medical LLC', 'Irvine Scientific Sales Company Inc. (a subsidiary of Fujifilm Holdings Corporation)', 'Thermo Fisher Scientific Inc.', 'Merck KGaA (through its subsidiary, Merck Serono S.A.)', 'Genea Limited', 'Boston IVF', 'OvaScience Inc. (a subsidiary of Millendo Therapeutics Inc.)', 'IGENOMIX', 'Progyny Inc.', 'Bloom IVF Group', 'IVI-RMA Global', 'CryoChoice LLC', 'Cryos International – USA', 'Cryopoint LLC', 'Reproductive Medicine Associates of New Jersey', 'CARE Fertility Group', 'The Fertility Partnership'.

What is the key driver of Global Assisted Reproductive Technology Market?

Rising prevalence of infertility is accelerating market growth

What is the key market trend for Global Assisted Reproductive Technology Market?

The increased acceptance of ART in society as a result of the adoption of more advanced technologies such as Endometrial Receptivity Analysis Testing (ERA), Pre-implantation Genetic Testing (PGT), Magnetic Activated Cell Sorting (MACS), and time-lapse imaging of embryos is expected to drive demand for assisted reproductive technology procedures. According to the CDC's 2019 Reproductive Clinic Success Rates Report, roughly 330,773 assisted reproductive technology operations were performed at 448 fertility clinics in the United States, accounting for 77,998 live births and 83,946 live-born infants. Furthermore, increased awareness regarding the causes and treatment of infertility is projected to move the market forward.

Which region accounted for the largest share in Global Assisted Reproductive Technology Market?

Europe dominated the market in 2021, accounting for more than 37.20% of total revenue. The large percentage can be linked to an increase in the rate of infertility, improved awareness about fertility treatments, technical developments, and supportive government activities. According to the European Society of Human Reproduction and Embryology, roughly 25 million people in the European Union suffer from infertility, which is the highest rate in the world. During the predicted period, North America is expected to increase significantly. The beneficial outcomes obtained by patients undergoing treatment are linked to the growth.

Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Product(Instrument, Accessory & Disposable and Reagents & Media), By Technology(In Vitro-Fertilization, Artificial Insemination and Others), By End User(Fertility Clinic, Hospital, Surgical Center and Clinical Research Institute), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35G2228 | Region: Global | Published Date: July, 2024
Pages: 165 | Tables: 91 | Figures: 76

Assisted Reproductive Technology Market Competitive Landscape

Assisted Reproductive Technology Market Top Players Company Profiles

Ferring Pharmaceuticals (Switzerland)
CooperSurgical, Inc. (US)
IVF Technologies (USA)
Merck KGaA (Germany)
Genea Biomedx (Australia)
Hamilton Thorne Ltd. (Canada)
Vitrolife AB (Sweden)
LABORIE (Canada)
ESN (France)
MedTec (USA)
CryoLife, Inc. (USA)
Nantong Egens Biotechnology Co., Ltd. (China)
Research Instruments Ltd. (UK)
Sartorius AG (Germany)
Thermo Fisher Scientific Inc. (USA)

Assisted Reproductive Technology Market Recent Development

In June 2024, A novel ovarian stimulation drug with the potential to improve egg quality and increase the success rate of in vitro fertilization (IVF), EndoStim-X was launched by Ferring Pharmaceuticals (Switzerland). Such advances indicate Ferring’s commitment to ART innovation and an effort to develop better treatment options for patients undergoing assisted reproduction.
In July 2024, Hamilton Thorne Ltd. (Canada) is a company that introduced EmbryoView Pro, a state-of-the-art embryo monitoring technology. This modern system combines AI-based analysis for instant embryo evaluation and thus helps increase precision and enhance ART outcomes. This was in line with Hamilton Thorne’s intent to use technology to advance reproductive medicine.
In August 2024, A new embryo culture medium called VitroEnhance was introduced by Vitrolife AB (Sweden). With the help of this medium, implantation success rates will rise, and embryo development will be optimised. With constant innovation in reproductive technology and research, Vitrolife is striving to improve the success of ART, as seen by its most recent offering.

Assisted Reproductive Technology Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Assisted Reproductive Technology Market size was valued at USD 25.30 Billion in 2022 poised to grow from USD 26.67 Billion in 2023 to USD 40.67 Billion by 2031, growing at a CAGR of 5.40% in the forecast period (2024-2031).

Global aided reproductive technology (ART) market is highly competitive as major companies pursue innovative solutions through advanced technologies. Key players include CooperSurgical who offers a variety of ART products, IVF Technologies which was the first to develop ART techniques and Ferring Pharmaceuticals widely recognized for its fertility drugs. To improve success rates and meet increasing demand for ART worldwide, these companies are engaged in R&D activities, forming alliances and expanding their services. 'Ferring Pharmaceuticals (Switzerland) ', 'CooperSurgical, Inc. (US) ', 'IVF Technologies (USA) ', 'Merck KGaA (Germany) ', 'Genea Biomedx (Australia) ', 'Hamilton Thorne Ltd. (Canada) ', 'Vitrolife AB (Sweden) ', 'LABORIE (Canada) ', 'ESN (France) ', 'MedTec (USA) ', 'CryoLife, Inc. (USA) ', 'Nantong Egens Biotechnology Co., Ltd. (China) ', 'Research Instruments Ltd. (UK) ', 'Sartorius AG (Germany) ', 'Thermo Fisher Scientific Inc. (USA) '

Infertility rates are increasing due to factors such as late childbearing, changes in lifestyle and environmental interactions; hence ART becomes very crucial. More and more couples want to solve their infertility problems, resulting in more demand for these services leading to increased growth of this industry.

Expansion of Personalized ART Solutions: Due to advancements made in genetic screening and embryo analysis, the market is increasingly tilting in favor of individualized ART therapies. These tailored approaches aim at enhancing success rates and producing more efficient and focused fertility treatments by tackling the causes of infertility and considering individual patient concerns.

Owing to its massive investments in health care administration, expanding human population and increasing infertility cases, the Asia-Pacific region is the kingpin of the global assisted reproductive technology market. Countries such as China and India are in need of assisted reproductive technologies (ART) because of changing social norms, rising awareness levels and easier access to modern reproductive technology. The region also gains from increased government funding, changing laws and policies, and an increase in fertility clinics providing state-of-the-art care. These elements coming together, combined with enhanced healthcare systems and economic growth, puts Asia-Pacific as a prominent market for ART, spurring its innovation and growth.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Assisted Reproductive Technology Market Competitive Landscape

Assisted Reproductive Technology Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Assisted Reproductive Technology Market?

Who are the key vendors in the Assisted Reproductive Technology Market?

What is the key driver of Assisted Reproductive Technology Market?

What is the key market trend for Assisted Reproductive Technology Market?

Which region accounted for the largest share in Assisted Reproductive Technology Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300